You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 微創醫療(0853.HK)續漲4.5% 戰略投資穿刺醫療器械公司
格隆匯 05-07 15:51
格隆匯5月7日丨微創醫療(0853.HK)現報19.04港元,漲幅4.5%,最新總市值329.8億港元。公司昨日公告稱,與包括NDR在內的合作方訂立正式協議,以帶領對NDR進行800萬新加坡元的戰略性投資,其中公司承諾投資600萬新加坡元,以換取NDR約20.9%的經擴大股權。公司附屬公司亦已與NDR及上海佑隆訂立協議,成立一家中國合營公司,以申請NMPA監管批准並使NDR的穿刺導航機器人系統商業化等活動。NDR主要從事研發用於經皮腎結石移除及/或經皮肺活檢及消融手術的穿刺導航機器人系統的醫療器械公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account